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UNIT 4.30Production of a Heterozygous Mutant
Cell Line by Homologous Recombination
(Single Knockout)
Gene targeting by homologous recombination allows the introduction of specific muta-
tions into any cloned gene. In the method described here, the gene of interest is inactivated
by interrupting its coding sequence with a positive selectable marker (e.g., neo). Expres-
sion of neo is obtained by including the phosphoglycerate kinase (PGK) promoter in the
construct. To enrich for clones in which the target gene has undergone homologous
recombination over those in which random integration of the construct has occurred, a
negative selectable marker, herpes simplex virus thymidine kinase (HSV-TK), is included
in the construct outside the region of homology to the target gene. Depending upon the
target gene, it may be easier to assemble the construct by adding the neo and TK genes
to the cloned target gene or by adding two fragments of the target gene to a plasmid
containing the neo and TK genes (e.g., pNTK; Fig. 4.30.1).
If the Cre-loxP system (UNIT 4.29) is to be used for removing the selectable marker, or for
tissue-specific or temporally controlled knockout, then a construct already containing
loxP sites flanking the marker is more convenient (e.g., pTKLNL; Fig. 4.30.2A). If
selection for loss of selectable marker is desired, a construct that also contains a negative
selectable marker can be used (e.g., pTKLNCL; Fig. 4.30.2B).
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Figure 4.30.1 pNTK vector. Both the neo and TK genes are driven by a PGK promoter (PPGK)
that is expressed in ES cells. Unique restriction enzyme sites that are useful are indicated in bold.
One genomic fragment can be cloned into the BamHI site. A second genomic fragment can be
cloned into the HindIII, ClaI, Sal I, XhoI sites. A site should be preserved that will linearize the

















































































Figure 4.30.2 Constructs containing loxP sites surrounding a positive selectable marker, neo (A),
or both a positive and a negative selectable marker, neo and cytosine deaminase (CD; B).
Constructs can be made by insertion of homologous sequences in unique restriction sites outside
the loxP sites. If conditional targeting constructs are desired (as in Fig. 4.29.7), a third loxP site can
be inserted into the region of homology and then the two regions of homology inserted into the
vectors. Another version of these plasmids is also available with the TK and CD reversed (Milstone
et al., 1999).






Figure 4.30.3 illustrates the production, selection, and identification of targeted gene
disruption by homologous recombination. A replacement targeting construct requires the
assembly of several different DNA sequences:
1. A genomic clone (preferably >10 kb) of the gene of interest, generally encoded on a
bacteriophage or cosmid clone containing homologous sequences to be included in
the construct. DNA isogenic to the ES cells (i.e., derived from the same animal strain)
is preferred but not essential. An alternative for genes of sufficient size, and regions













































Figure 4.30.3 Production, selection, and identification of targeted gene disruption by homologous
recombination. An example of a restriction enzyme site (RE) and hybridization probe that can be
used to identify cells in which homologous recombination has occurred (shaded colony) is shown.
The predicted size of the restriction fragment generated from an unaltered target gene (E) and a
target gene that has undergone homologous recombination (HR) is shown. If equal amounts of
DNA are present in the lanes of the Southern blot, the intensity of each of the two hybridizing
fragments from the DNA of a homologous recombinant clone will be half of the intensity of the
hybridizing fragment from unaltered clones.





approach works for many genes as long as they have large enough introns, and is
particularly convenient when the intron-exon structure of the gene is known. Long
PCR may introduce mutations, which may decrease homologous recombination rates
just as nonisogenic DNA can. In addition, the mutations may occur in important parts
of the gene; this risk makes the approach less suitable for conditional knockouts or
subtle mutations.
2. Additional cloned target-gene DNA sequences not included in the construct, to be
used as a hybridization probe to identify homologous recombinants. This probe can
often be isolated from the same bacteriophage or cosmid clone that provided the
homologous sequences included in the construct. The hybridization probe will
hybridize with either an unaltered target gene or a target gene that has undergone
homologous recombination, but will not hybridize with a construct that entered the
genome by random integration.
3. A positive selectable marker, such as the gene encoding neomycin phosphotrans-
ferase (neo) or hygromycin-B-phosphotransferase (hyg), which is used to disrupt the
target gene. If a homozygous mutant cell line is an ultimate goal, it is recommended
that the neo coding sequence contain the point mutation that decreases the phos-
photransferase activity (Yenofsky et al., 1990). Using the PGK promoter and the
wild-type neo gene may result in cells containing a single neo gene that are resistant
to >10 mg/ml G418, thus precluding the use of higher G418 concentration to isolate
clones containing two neo genes (see CPMB UNIT 23.6).
4. A negative selectable marker such as HSV-TK, which is used to enrich for ES cell
clones in which homologous recombination has occurred in the target gene over
clones in which random integration of the construct has occurred.
BASIC
PROTOCOL
GENE TARGETING IN EMBRYONIC STEM CELLS
The basic protocol is divided into three parts. First, it outlines the assembly of a
replacement targeting construct and considerations in choosing its exact structure. Sec-
ond, it briefly describes the culture of embryonic stem (ES) cells and the method for
introducing the construct DNA into ES cells. A more detailed description of culturing ES
cells and maintaining their undifferentiated state is found in CPMB UNITS 23.2 & 23.3. Third,
it outlines the method for identifying clones in which the target gene has been altered by
homologous recombination. The resulting homologous recombinants are heterozygous
(one allele of the target gene is altered by homologous recombination and one allele is
normal) and can be used to produce transgenic murine lines or to produce homozygous
mutant cell lines (in which both alleles of the target gene are altered; CPMB UNIT 23.6).
Materials
Target gene from genomic library isogenic with ES cell line (e.g., 129 SV
library; Stratagene)
Plasmid vector (e.g., pNTK, available from R. Mortensen; see Fig. 4.30.1)
95% ethanol
Sterile H2O
Embryonic stem (ES) cells (see CPMB UNITS 23.2 & 23.3 and APPENDIX 1A in this
manual; ATCC)
ES/LIF medium (see recipe)
Trypsin/EDTA: 0.25% (w/v) trypsin/1 mM EDTA (20 mM HEPES,
pH 7.3, optional)
ES medium (see recipe)
Electroporation buffer (see recipe)







Freezing medium (see recipe)
Digestion buffer (see recipe)
Saturated NaCl (see recipe)
1% agarose gel (APPENDIX 1N)
Tissue culture hood
Gelatin-coated tissue culture plates (CPMB UNIT 23.3): 100-mm plates and 24-well
microtiter plates
4-mm electroporation cuvettes
Pipet tips, sterilized by autoclaving
Nylon membrane
Additional reagents and equipment for subcloning DNA (see CPMB UNIT 3.16 and
APPENDIX 1A in this manual), restriction enzyme digestion (APPENDIX 1M),
phenol/chloroform extraction of DNA (APPENDIX 1G), agarose gel electrophoresis
(APPENDIX 1N), electroporation (APPENDIX 1E), ES cell culture (APPENDIX 3B), stable
transformation using selective medium (see CPMB UNIT 9.5 and APPENDIX 1A in this
manual), and Southern blotting and hybridization (see CPMB UNITS 2.9 & 2.10 and
APPENDIX 1A in this manual)
NOTE: All tissue culture incubations should be performed in a humidified 37°C, 5% CO2
incubator unless otherwise noted.
Create a replacement construct
1. Select a portion of the target gene to include in the construct and a separate portion
of the target gene to use as a probe for hybridization of Southern blots to identify
cells in which homologous recombination has occurred (see step 19).
It should contain a rare restriction site within an exon encoding an important region of the
protein (or an exon upstream of such a region) that is ideally flanked by >1 kb of target
gene DNA on each side (most constructs are made with 2 kb). The rate of homologous
recombination may increase with increasing lengths of homologous DNA up to 15 kb.
2. Construct a clone in a plasmid vector (see CPMB UNIT 3.16) such that the neo gene
interrupts the gene of interest, leaving regions of homology on either side of the neo
gene. Include a thymidine kinase (TK) gene in the replacement construct outside the
regions of homology (Fig. 4.30.4).
This construction can be accomplished by either adding the neo and TK sequences to the
subcloned homologous sequences or by adding regions of homologous sequences to a
plasmid already containing the neo and TK genes (e.g., pNTK; see Fig. 4.30.1).
3. Digest the construct DNA with a restriction enzyme to linearize (APPENDIX 1M).
Linearize the construct DNA so that the plasmid vector sequences remain attached to the
TK gene. This will help preserve the activity of TK gene if any loss of DNA sequence occurs
during random insertion of the construct into the genome.
4. Purify and sterilize the digested construct DNA by phenol/chloroform extraction
(APPENDIX 1G).
5. Precipitate the DNA by adding 2 vol of 95% ethanol and microcentrifuging 30 sec.
Using sterile technique in a tissue culture hood, remove the supernatant and allow
the pellet to air dry until only slightly moist.
6. Dissolve the pellet in 100 µl sterile water. Check for complete digestion and estimate
DNA concentration by electrophoresis on an agarose gel (APPENDIX 1N).





Transfect construct and select ES cells
7. Culture ES cells in ES/LIF medium (APPENDIX 1B). Passage cells every 2 to 3 days by
seeding a 100-mm gelatin-coated tissue culture plate with 1–2 × 106 cells/plate.
Leukemia inhibitory factor (LIF) prevents ES cells from differentiating.
Some investigators suggest passaging cells at a higher density if blastocyst injection of the
cells (CPMB UNIT 23.4) is planned (e.g., 1.5 × 106 cells per 25-cm2 flask). A detailed
description of culture techniques for ES cells is found in CPMB UNITS 23.2 & 23.3.
8. Harvest ∼5 × 106 to 1 × 107 cells by adding trypsin/EDTA and incubating for ∼5 min
until cells are freed from the plate surface. Dissociate to single cells by pipetting up
and down five to ten times. Add 5 ml ES medium. Pellet cells and resuspend the cell
pellet in 1 ml electroporation buffer in the same tube.
Typically, 1 × 107 cells can be obtained from a near-confluent 100-mm tissue culture plate.
9. Add 1 pmol linearized, sterile construct DNA from step 6.
10. Electroporate the mixture at 450 V and 250 µF in a 4-mm electroporation cuvette
(APPENDIX 1E). Incubate 10 min at room temperature.
Many electroporation conditions can be used with ES cells (APPENDIX 1E).
11. Plate cells in ES medium at ∼2 × 106 cells per 100-mm gelatin-coated tissue culture
plate. Incubate 24 hr.
12. Begin selection (see CPMB UNIT 9.5) by changing ES medium to ES/LIF medium and
















construct and target gene
target gene
A B
Figure 4.30.4 Two strategies to create a replacement construct. In method A the target gene
fragment is subcloned into a plasmid vector, then PPGK-neo is inserted into a rare restriction enzyme
site in the target-gene fragment and PPGK-TK is inserted into the plasmid vector near the target
gene. In method B the target-gene fragment is cleaved into two pieces that are subcloned into the
polylinker sites of pNTK (see Fig. 4.30.1). Note that the relative orientation of homologous fragments
in the construct must retain that found in the target gene.





13. Continue incubation, changing medium daily using ES/LIF medium and adding
G418 (0.2 mg/ml final) and GANC (2 µm final), until single, isolated colonies are
visible (typically 1 week after electroporation). Remove an individual colony from
the plate using an autoclaved pipet tip, and place in a 35-µl drop of trypsin/EDTA for
5 min. Pipet up and down about five times to dissociate cells. Transfer cells to a well
of a gelatin-coated 24-well microtiter plate containing 1 ml ES/LIF medium.
14. Incubate until colonies are visible, but the cells are not differentiating (typically 3 to
4 days). Passage half of the cells to a well of a clean gelatin-coated 24-well microtiter
plate. Add the remaining cells to 0.5 ml freezing medium and place at −70°C. Freeze
overnight, then transfer to liquid nitrogen.
Undifferentiated cells grow in smooth, round colonies. Differentiated cells are flatter with
distinct intercellular boundaries.
Proceed immediately to step 15 after placing half the cells in the freezer.
Screen for homologous recombinants
15. Incubate ES cells in 24-well microtiter plate (step 14) to near confluence (usually 2
to 3 days).
Because it is not critical to prevent differentiation of the ES cells at this stage, LIF can be
omitted from the culture medium; however, the presence of LIF may help to maintain cell
growth.
16. Add 300 µl digestion buffer to each well. Transfer well contents to a 1.5-ml
microcentrifuge tube, and incubate overnight at 55°C.
17. Add 150 µl saturated NaCl and vortex vigorously (the solution will turn milky white).
Add 2 vol of 95% ethanol (the solution will turn clear except for precipitated DNA).
Some investigators precipitate the DNA using 2 vol ethanol (or 1 vol isopropanol) without
adding salt. However, the DNA pellet resuspends more easily if salt is added.
18. Resuspend DNA pellet in 50 µl water. Determine DNA concentration by measuring
the absorbance at 260 nm (APPENDIX 1K).
19. Digest 10 µg DNA (or 10 µl if DNA concentration was not determined) with the
appropriate restriction enzyme (APPENDIX 1N).
20. Fractionate the digested DNA on a 1% agarose gel (CPMB UNIT 2.5A). Transfer to a
nylon membrane, and hybridize by Southern blotting (see CPMB UNITS 2.9 & 2.10) to the
target-gene hybridization probe chosen in step 1 to distinguish the unaltered target
gene from a target gene that has undergone homologous recombination.
21. Select ES cell colonies that show two hybridizing fragments of approximately equal
intensity—one fragment of the predicted size for the unaltered target gene and one
fragment of the predicted size for a target gene that has undergone homologous
recombination. If the two fragments are of unequal hybridization intensity, the cell
population may not be clonal. Freeze cells and store in liquid nitrogen.
22. If desired remove selectable markers that are flanked by loxP sites by transient
expression of Cre (see Support Protocol).







TRANSIENT EXPRESSION OF CRE FOR RECOMBINATION
Removal of sequences between the lox sites is accomplished by transient expression of
Cre recombinase. If flanking lox sites are present in both alleles, Cre will recombine both
alleles as efficiently as one. If selectable markers are between lox sites (as in Fig. 4.29.6),
then sensitivity to selection media (e.g., containing G418) will be restored.
Additional Materials (also see Basic Protocol)
Cre expression plasmid using a promoter giving high expression levels in ES cells
(e.g., pMC1 or pPGK)
12.5 mg/ml 5-fluorocytosine in PBS (if selecting against CD), sterile
1. Expand the homologously recombined clones obtained using the Basic Protocol by
culturing and harvesting ES cells (see Basic Protocol, steps 7 and 8).
2. Prepare Cre expression plasmid DNA using the same procedure as for the original
targeting vector (see Basic Protocol, steps 4 to 6).
Do not linearize the DNA, as this will increase the probability of genomic integration.
3. Use 1 to 2 pmol of this DNA to transfect the expanded ES cell clones (see Basic
Protocol, step 10).
Transfecting more DNA will most likely increase expression; however, it also increases the
probability of integration.
4. Plate cells at a lower density than for the original targeting (since survival is expected
to be higher).
The target is the number of clones per plate that will allow convenient colony picking. If
no selection is to be performed, plating at a few hundred electroporated cells per 100-mm
plate is a reasonable starting point. A range of dilutions should be plated (at least to a few
thousand per plate), since the exact survival is not accurately predictable and plating at
low density will decrease survival. If the negative selectable marker cytosine deaminase
(CD) is used, then plate at 1,000 to 10,000 cells per 100-mm plate, since higher densities
will give complete killing due to a neighbor selection effect. The number of surviving
colonies will depend on the frequency of recombination.
5. Continue to culture cells, replacing medium daily with fresh ES/LIF medium. If
selecting against CD, include 250 µg/ml 5-fluorocytosine (from 12.5 mg/ml stock)
in the medium.
6. Screen colonies for loss of the selectable marker (Cre-induced recombination) by
Southern analysis (see Basic Protocol, steps 14 to 21).
Although Cre-construct integration is an unlikely event, the clones for injection can also
be screened for presence of Cre by reprobing the Southern blots or by PCR.
REAGENTS AND SOLUTIONS
Use deionized, distilled water in all recipes and protocol steps. For common stock solutions, see
APPENDIX 2A; for suppliers, see SUPPLIERS APPENDIX.
Digestion buffer
20 mM Tris⋅Cl, pH 8.0 (APPENDIX 2A)
10 mM NaCl
10 mM EDTA
0.5% (w/v) sodium dodecyl sulfate (SDS)
Store indefinitely at room temperature
Add 1 mg/ml proteinase K just before use











0.1 mM 2-mercaptoethanol (2-ME)
Store indefinitely at 4°C
ES medium
Dulbecco’s minimum essential medium (DMEM), high-glucose + pyruvate formu-
lation, containing:
15% FBS, heat-inactivated 1 hr at 56°C
0.1 mM 2-mercaptoethanol (2-ME)
20 mM HEPES, pH 7.3 (optional)
DMEM containing 4500 mg/liter D-glucose and pyruvate can be obtained from Life Tech-
nologies.
A detailed description of culture conditions for embryo stem cells has been presented by
Robertson (1987).
ES/LIF medium
ES medium (see recipe) containing 1000 U/ml leukemia inhibitory factor (LIF; Life
Technologies). Store ≤1 week at 4°C.
Conditioned medium from a CHO cell line overproducing LIF (Genetics Institute) can also
be used at a dilution of 1:1000. An alternative to LIF for preventing differentiation of ES
cells is to grow them on feeder layers of irradiated mouse embryo fibroblasts (MEF) in ES
medium. Some investigators add 20 mM HEPES (pH 7.3) to culture medium.
Freezing medium
DMEM, high-glucose + pyruvate formulation, containing:
10% FBS (Hyclone), heat-inactivated 1 hr at 56°C
10% (v/v) dimethylsulfoxide (DMSO)
20 mM HEPES, pH 7.3 (optional)
Store at −20°C
Saturated NaCl
Add NaCl to distilled H2O until no more dissolves (∼6 M). Some solid NaCl should
remain; decant solution for use. Store indefinitely at room temperature.
COMMENTARY
Background Information
See UNIT 4.29 for an overview of gene target-
ing by homologous recombination.
Although homologous recombination has
been used by yeast geneticists for some time, it
has only recently been shown to occur in somatic
mammalian cells. It was first demonstrated be-
tween exogenously introduced DNA sequences
(Folger et al., 1982) and later between an exo-
genously introduced DNA construct and an en-
dogenous gene (Smithies et al., 1985).
The mechanism of homologous recombina-
tion is not well understood but a number of
characteristics are known. Homologous recom-
bination occurs more readily if the construct
has free ends, rather than being circular (Wong
and Capecchi, 1987). The rate of homologous
recombination does not depend on the number
of targets in the genome—at least when the
target is present as tandem repeats of a dihy-
drofolate reductase (DHFR) amplified gene
(Zheng and Wilson, 1990).
Initially, homologous recombination in
mammalian cells was studied by introducing a
mutated neo or TK gene, then restoring neo or
TK activity by correcting the mutation through
homologous recombination (reviewed by
Capecchi, 1989). This approach provided an
easy method to detect homologous recombi-
nation.





Embryonic stem (ES) cells and the related
embryonic carcinoma (EC or EK) cells were
first isolated and cultured in 1981 (Evans and
Kaufman, 1981; Martin, 1981). They can give
rise to a chimeric mouse when introduced into
a normal blastocyst, which is then transferred
into the uterus of a pseudopregnant foster
mother. The ES cells contribute to all tissues of
the chimeric mouse including the germ line
(Bradley et al., 1984). Currently, ES cells,
rather than EC cells, are used to produce
chimeric mice, because the extent of chimerism
and efficiency of germ line transmission is
much higher with normal cells. Most ES cell
lines used are derived from males because the
karyotype of XY cells is more stable than that
of XX cells and resulting chimeric male mice
are easier to breed. Typically, the extent of the
contribution of the ES cells to somatic tissues
of the chimeric mouse is easily determined
visually by choosing strains of mice for the
sources of ES cells and blastocysts that have
different coat colors.
Critical Parameters
The degree of homology between the con-
struct and the target genome can have a dra-
matic effect on the rate of homologous recom-
bination in two ways. First, homologous re-
combination requires stretches of exact DNA
homology. The DNA used to construct the tar-
geting vector must be from the same species as
the cell in which the mutation is to be intro-
duced. It should also be isogenic with the target
cell (this is not absolutely required, but in-
creases the probability of success). Because
animal strains may differ just as individual
outbred animals differ, there may be a mis-
match of DNA on average every 500 bp. A
single DNA mismatch is sufficient to dramati-
cally decrease the rate of homologous recom-
bination (Deng and Capecchi, 1992; teRiele et
al., 1992). Mutations induced by making con-
structs using long PCR may similarly decrease
homologous recombination rates.
Second, the rate of homologous recombina-
tion increases with increasing length of the
homologous DNA sequence (within limits).
The exact length of homologous DNA that
gives the maximum recombination rate is con-
troversial but may be as high as 15 kb (Deng
and Capecchi, 1992; Hasty et al., 1991). Ho-
mology should also be >1 kb for the shorter arm
(most constructs have used >2 kb). Further,
fidelity of recombination can be lower if the
length of homology is <1 kb (Thomas et al.,
1992).
The parameters outlined here are meant to
be guidelines for the design of constructs. For
some target genes and constructs, more or less
homology may be required. Nonisogenic DNA
recombines easily for some genes. If homolo-
gous recombination is not obtained initially, the
same construct should be retransfected into the
ES cells, as the rate of homologous recombina-
tion can vary for unclear reasons. A second
construct using a different region of the gene
can also be used because different constructs of
the same gene may recombine at different rates.
If homologous recombination is occurring, but
only at a low rate, screening pools of clones by
the polymerase chain reaction (PCR) may en-
able one to identify homologous recombinants
(Koller et al., 1991).
Anticipated Results
In most cases, constructs prepared following
the above guidelines should give rise to a num-
ber of homologous recombinant clones in a
single transfection. Typically the frequency of
homologous recombinant clones to surviving
clones is 1:30 to 1:5; however, the range of
reported results is large: the ratio may be
≤1:1000, or homologous recombinants may
even be in the majority.
The frequency of recombination reported in
the literature varies from 1% to 16%; in the
authors’ hands, it has sometimes been as high
as 30%.
Time Considerations
The entire procedure, from cloning to ob-
taining homologous clones, can take several
months, depending on the difficulty in obtain-
ing the construct. Once a construct is obtained,
however, transfection and selection of clones
takes ∼2 weeks. Screening clones takes 2 to 3
days. Addition of a neo removal step will add
∼4 weeks for expansion of clones, transfection,
and rescreening.
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Gene Cloning,
Expression, and
Mutagenesis
